martes, 9 de julio de 2024

CDRH MedSun Newsletter: July 2024, Volume 24, Issue 7

https://content.govdelivery.com/accounts/USFDA/bulletins/3a756b1?reqfrom=share The U.S. Food and Drug Administration’s (FDA) MedSun program provides this monthly newsletter to inform patients and patient advocates about FDA information on medical device related topics. The MedSun program, launched in 2002 by the FDA’s Center for Devices and Radiological Health (CDRH), uses a secure online reporting system to receive medical device adverse event reports from a network of over 300 clinical facilities across the United States. MedSun sites work collaboratively with the FDA to assist in detecting, understanding, and sharing information concerning the safety of medical products and play a critical role in the FDA’s postmarket surveillance efforts.

No hay comentarios: